Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice

BioFactors

Volumn 20, Issue 1, 2004, Pages 49-59

  Naito, Yuji ^a,d   Uchiyama, Kazuhiko ^a   Aoi, Wataru ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a   Yoshida, Norimasa ^a   Maoka, Takashi ^b   Takahashi, Jiro ^c   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Sun Biolex Co   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^d Graduate School of Medicine   (Japan)

Author keywords

8 hydroxydeoxyguanosine; Astaxanthin; Diabetic nephropathy; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; ASTAXANTHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG ACTIVITY; FEMALE; GLOMERULUS; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASE; MESANGIUM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RODENT;

ALGAE; ANIMALIA; AVES; GLOMERULUS; RODENTIA;

EID: 2342651486     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520200105     Document Type: Article

References (42)

1. F.N. Ziyadeh, The extracellular matrix in diabetic nephropathy, Am J Kidney Dis 22 (1993), 736-744.
2. D. Zhu, Y. Kim, M.W. Steffes, T.J. Groppoli, R.J. Butkowski and S.M. Mauer, Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry, Kidney Int 45 (1994), 425-433.
3. T.D.C.a.C.T.R. Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med 329 (1993), 977-986.
4. U.P.D.S.U. Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33), Lancet 352 (1998), 837-853.
5. R. Kikkawa, D. Koya and M. Haneda, Progression of diabetic nephropathy, Am J Kidney Dis 41 (2003), S19-S21.
6. T. Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonta, H. Utsumi, H. Sumimoto, H.Y. Yu, N. Sonoda, M. Inuo, N. Sato, N. Sekiguchi, K. Kobayashi and H. Nawata, A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase, Curr Med Chem 10 (2003), 1759-1764.
7. D. Koya, K. Hayashi, M. Kitada, A. Kashiwagi, R. Kikkawa and M. Haneda, Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats, J Am Soc Nephrol 14(Suppl 3) (2003), S250-S253.
8. A.C. Maritim, R.A. Sanders and J.B. Watkins, Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rat, J Nutr Biochem 14 (2003), 288-294.
9. H. Kaneto, Y. Kajimoto, J. Miyagawa, T. Matsuoka, Y. Fujitani, Y. Umayahara, T. Hanafusa, Y. Matsuzawa, Y. Yamasaki and M. Hori, Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity, Diabetes 48 (1999), 2398-2406.
10. M.A. Catherwood, L.A. Powell, P. Anderson, D. McMaster, P.C. Sharpe and E.R. Trimble, Glucose-induced oxidative stress in mesangial cells, Kidney Int 61 (2002), 599-608.
11. J.M. Li and A.M. Shah, ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy, J Am Soc Nephrol 14(Suppl 3) (2003), S221-S226.
12. M.R. Clarkson, M. Murphy, S. Gupta, T. Lambe, H.S. Mackenzie, C. Godson, F. Martin and H.R. Brady, High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly, J Biol Chem 277 (2002), 9707-9712.
13. T. Yoshikawa and Y. Naito, What is oxidative stress? JMAJ 45 (2002), 271-276.
14. J. Leinonen, T. Lehtimaki, S. Toyokuni, K. Okada, T. Tanaka, H. Hiai, H. Ochi, P. Laippala, V. Rantalaiho, O. Wirta, A. Pasternack and H. Alho, New biomarker evidence of oxidative DNA damage in patients with non-insulin- dependent diabetes mellitus, FEBS Lett 417 (1997), 150-152.
15. M. Kanauchi, H. Nishioka and T. Hashimoto, Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy, Nephron 91 (2002), 327-329.
16. T. Nishikawa, T. Sasahara, S. Kiritoshi, K. Sonoda, T. Senokuchi, T. Matsuo, D. Kukidome, N. Wake, T. Matsumura, N. Miyamura, M. Sakakida, H. Kishikawa and E. Araki, Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes, Diabetes Care 26 (2003), 1507-1512.
17. Y. Hinokio, S. Suzuki, M. Hirai, M. Chiba, A. Hirai and T. Toyota, Oxidative DNA damage in diabetes mellitus: its association with diabetic complications, Diabetologia 42 (1999), 995-998.
18. Y.M. Naguib, Antioxidant activities of astaxanthin and related carotenoids, J Agric Food Chem 48 (2000), 1150-1154.
19. K. Fukuhara, Y. Inokami, A. Tokumura, J. Terao and A. Suzuki, Rate conctants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes, Lipids 33 (1998), 751-756.
20. M. Kobayashi, In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis, Appl Microbiol Biotechnol 54 (2000), 550-555.
21. H. Jyonouchi, L. Zhang, M. Gross and Y. Tomita, Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens, Nutr Cancer 21 (1994), 47-58.
22. H. Kurihara, H. Koda, S. Asami, Y. Kiso and T. Tanaka, Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress, Life Sci 70 (2002), 2509-2520.
23. B.P. Chew, J.S. Park, M.W. Wong and T.S. Wong, A comparison of the anticancer activitaies of dietary bata-carotene, canthaxanthin and astaxanthin in mice in vivo, Anticancer Res 19 (1999), 1849-1853.
24. M. Bennedsen, X. Wang, R. Willen, T. Wadstroem and L.P. Andersen, Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulated cytokine release by splenocytes, Immun Letters 70 (1999), 185-189.
25. K. Ohgami, K. Shiratori, S. Kotake, T. Nishida, N. Mizuki, K. Yazawa and S. Ohno, Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo, Invest Ophthalmol Vis Sci 44 (2003), 2694-2701.
26. J. Steinbrenner and H. Linden, Light induction of carotenoid biosynthesis genes in the green alga Haematococcus pluvialis: regulation by photosynthetic redox control, Plant Mol Biol 52 (2003), 343-356.
27. G.A. Spiller and A. Dewell, Safety of an Astaxanthin-Rich Haematococcus pluvialis Algal Extract: A Randomized Clinical Trial, J Med Food 6 (2003), 51-56.
28. K. Uchiyama, Y. Naito, G. Hasegawa, H. Nakamura and T. Yoshikawa, Astaxanthin preserves pancreatic beta-cells in db/db mice, Redox Report in press (2002).
29. K. Sharma, P. McCue and S.R. Dunn, Diabetic kidney disease in the db/db mouse, Am J Physicl Renal Physiol 284 (2003), F1138-F1144.
30. C. Sassy-Prigent, D. Heudes, S. Jouquey, D. Auberval, M.F. Belair, O. Michel, G. Hamon, J. Bariety and P. Bruneval, Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition, Lab Invest 73 (1995), 64-71.
31. S. Toyokuni, Y. Iwasa, S. Kondo, T. Tanaka, H. Ochi and H. Hiai, Intranuclear distribution of 8-hydroxy-2′-deoxyguanosine. An immunocytochemical study, J Histochem Cytochem 47 (1999), 833-836.
32. B.S. De Martinis and M.D. Bianchi, Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats, Pharmacol Res 44 (2001), 317-320.
33. Y. Minamiyama, S. Takemura, S. Toyokuni, Y. Nishino, K. Yamasaki, S. Hai, S. Yamamoto and S. Okada, Amelioration of cisplatin toxicity by a fermented grain food product, Biofactors 16 (2002), 105-115.
34. S. Inoue, S. Koya-Miyata, S. Ushio, K. Iwaki, M. Ikeda and M. Kurimoto, Royal Jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage, Exp Gerontol 38 (2003), 965-969.
35. H. Ha, C. Kim, Y. Son, M.H. Chung and K.H. Kim, DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 16 (1994), 271-274.
36. Y. Hinokio, S. Suzuki, M. Hirai, C. Suzuki, M. Suzuki and T. Toyota, Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy, Diabetologia 45 (2002), 877-882.
37. K. Kouda, H. Nakamura, W. Fan, K. Horiuchi and H. Takeuchi, The relationship of oxidative DNA damage marker 8-hydroxydeoxyguanosine and glycoxidative damage marker pentosidine, Clin Biochem 34 (2001), 247-250.
38. Y. Naito, G. Hasegawa, N. Nakamura, E. Ichiishi, H. Ochi and T. Yoshikawa, Urinary 8-Hydroxy-2′-deoxyguanosine excretion in diabetes mellitus, TE Letters 3 (2002), 92-96.
39. Y. Ueno, M. Kizaki, R. Nakagiri, T. Kamiya, H. Sumi and T. Osawa, Dietary glutathione protects rats from diabetic nephropathy and neuropathy, J Nutr 132 (2002), 897-900.
40. S. Goto, K. Kogure, K. Abe, Y. Kimata, K. Kitahama, E. Yamashita and H. Terada, Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin, Biochim Biophys Acta 1512 (2001), 251-258.
41. W. Aoi, Y. Naito, K. Sakuma, M. Kuchide, H. Tokuda, T. Maoka, S. Toyokuni, S. Oka, M. Yasuhara and T. Yoshikawa, Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice, Antioxid Redox Signal 5 (2003), 139-144.
42. P. Graede, H.E. Poulsen, H.H. Parving and O. Pedersen, Double-blind, randomized study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients, Diabet Med 18 (2001), 756-760.